Last reviewed · How we verify
Saliva sample collection
At a glance
| Generic name | Saliva sample collection |
|---|---|
| Sponsor | Direction Centrale du Service de Santé des Armées |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- GCF and Saliva Levels of IL-36α in Periodontal Disease (NA)
- Blood Donor CVD 5000 (PHASE4)
- Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) (NA)
- Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status
- Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
- MIMICC Study in Patients With Colorectal Cancer (NA)
- The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease (NA)
- Biospecimen Procurement for Head and Neck Disorders
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Saliva sample collection CI brief — competitive landscape report
- Saliva sample collection updates RSS · CI watch RSS
- Direction Centrale du Service de Santé des Armées portfolio CI